Remap Consulting’s Post

At Every Cure, we're dedicated to developing the world's leading AI platform for drug repurposing predictions. As I stated yesterday on Cure.'s Tuesday Talks with Seema Kumar, we're not just relying on advanced technology but also on forging a path as a collaborative and non-competitive organization. Our goal is to harness the best datasets available—often those not typically shared within the pharmaceutical industry. By integrating diverse data sources, we enhance our AI's ability to identify potential new uses for generic drugs, which constitute about 80% of the 3000 drugs available. These are drugs that no longer have IP opportunities but hold immense potential for treating diseases. Moreover, we focus on the 10,000 rare diseases often overlooked by the pharmaceutical industry, reflecting our commitment to addressing unmet medical needs. This approach underscores the necessity of a charitable model, as it aligns more closely with our mission to serve underrepresented populations and neglected conditions. How can we further foster collaborations to drive innovation in treating rare diseases? #EveryCure #AIDrugRepurposing #HealthcareInnovation #GlobalHealth #RareDiseases

💡 What if drug repurposing beared the promise of providing new therapies for yet non-treatable diseases based on available therapeutics? First and foremost, by clinical programs directed to drug repurposing, new patients may get access to therapy perhaps for the first time, or current treatment may be improved. 👉 Additional upsides can be that time to market, and therewith time to patient is shorter compared to drug development programs based on new drugs, and that costs decrease.   🔎 NLO colleagues Mari Korsten, Jaap Mannaerts and Barend Bouma wrote an interesting article for BiotechNews & Life Sciences about “Unlocking the promise of drug repurposing”. 📚 Read the complete article here (page 28-29): https://lnkd.in/ejyMD3FX #BiotechNews #LifeSciences #drugrepurposing #NLO #innovation #pharma

Exciting developments are taking place in the #HumanCoagulationFactorVII market, with significant investments shaping the future of this critical segment. Key players are making strides in advancing treatments and expanding their market reach. Here's a quick update: Novo Nordisk has recently announced a substantial investment aimed at enhancing its research and development capabilities for Human Coagulation Factor VII therapies. The company is focusing on innovative treatments to improve patient outcomes and expand its market share. This investment reflects Novo Nordisk’s commitment to addressing unmet medical needs in hemophilia and related disorders. Novo Nordisk Read Report @ https://lnkd.in/gtrzddCj #HealthcareInnovation #Pharmaceuticals #Biotech #ClinicalResearch #MedicalResearch #HealthTech #InvestInHealth #Biopharma #PharmaNews #HealthcareInvestment #DrugDevelopment #Hemophilia #MedicalAdvances #HealthCareTrends #PharmaIndustry #HealthcareFunding #ResearchAndDevelopment #PharmaInvestment #ClinicalTrials #HealthCareNews #HumanCoagulationFactorVII #FactorVIIResearch #HemophiliaTreatment #NovoNordiskInvestment #CoagulationFactorVII #MarketTrends #MedicalInvestments #HealthcareBreakthroughs #PharmaceuticalInvestments #BiotechInvestments #ClinicalResearchNews #CoagulationTherapies #FactorVIIDevelopment #PharmaTrends #HealthcareFundingNews #BiopharmaInvestments #MedicalTechnology #DrugInnovation #HealthcareInvestmentTrends #PharmaR&D #ClinicalTrialsUpdate

Reuters Pharma USA 2024 Day 1 - The event showcased groundbreaking advancements in the pharmaceutical industry. - Key topics included the integration of artificial intelligence in drug discovery, personalized medicine, and the impact of regulatory changes on drug approval processes. - Speakers highlighted the potential of AI to streamline drug development, improve patient outcomes, and reduce costs. - Discussions also revolved around the growing importance of data analytics in optimizing clinical trials and predicting drug efficacy. - Attendees explored innovative strategies for tackling emerging health challenges, such as infectious diseases and mental health disorders. - Moreover, the event emphasized the importance of collaboration between pharmaceutical companies, regulatory bodies, and healthcare providers to drive innovation and ensure patient access to cutting-edge treatments. Overall, the event provided a comprehensive overview of the latest trends and developments shaping the future of the pharmaceutical landscape in the United States. #ReutersPharmaUSA2024 #REpharmaUSA AKT Health Inc.

𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚𝐥 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟏𝟔.𝟏𝟎 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟎.𝟖% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝. 𝙁𝙤𝙧 𝙈𝙤𝙧𝙚 𝙍𝙚𝙥𝙤𝙧𝙩 𝘿𝙚𝙩𝙖𝙞𝙡𝙨, 𝙑𝙞𝙨𝙞𝙩: https://lnkd.in/dRs9GfGV The #healthcare_analytical_testing_services_industry is currently undergoing significant expansion, encompassing a diverse array of diagnostic and investigative procedures. These procedures are designed to assess various aspects of patient health, disease conditions, and the effectiveness of treatments. Advanced analytical technologies and other indicators are employed in these services to aid in disease identification, prognosis, and monitoring. This, in turn, facilitates informed clinical decision-making and personalized patient care. Moreover, these services play a vital role in the pharmaceutical and biotechnology sectors by assisting in drug development, evaluating efficacy, and ensuring regulatory compliance throughout preclinical and clinical trials. #healthcareanalytics #analyticaltesting #healthcareservices #labtesting #clinicalresearch #pharmaceuticaltesting #biomedicaltesting #healthcareinnovation #medicalresearch #labservices 

The rare disease market has seen remarkable growth over the past decade, driven by regulatory incentives for orphan drugs and the commercial potential of high unmet-need diseases. However, despite significant pharma and biotech interest, numerous diseases still lack effective therapies. In our latest white paper, dive into our comprehensive analysis to understand the challenges and opportunities in rare disease drug development, and discover strategies to navigate this dynamic landscape. Download your copy here: https://lnkd.in/e993_6u7 #RareDisease #Pharma #Biotech #HealthcareInnovation #WhitePaper

30 Million European Patients Need Your Rare Disease Therapy: Navigate Market Access Now Europe's rare disease market is booming, but many life-saving therapies face barriers to entry. Our latest article, "The Geopolitics of Hope," reveals how to unlock this market's vast potential. Gain expert insights on: 💚 Navigating the complexities of European regulatory and commercial landscapes 💚 Overcoming reimbursement challenges and securing market access 💚 Building effective partnerships with stakeholders 💚 Partnering to accelerate your success Don't miss this essential guide for biotech and pharma companies developing rare disease therapies. https://lnkd.in/e2PZnDJ9 #raredisease #orphandiseases #genetherapy #pharma #biotech #marketaccess #EU #ema #drugdevelopment #patientcentricity

Discover how new medications are born with this detailed exploration of the initial stages of drug discovery. This content breaks down the complex journey of transforming scientific knowledge into potential therapies. From identifying disease targets to selecting the most promising drug candidates, each step is crucial in developing safe and effective treatments. #drugdiscovery #clinicaltrials #research #ClinicalTrialPhases #clinicalresearch #healthcare #medicine #pharma #healthtech #drugdevelopment #invitro #invivo #dphsindia #smo

🌟 We're delighted to present our new content section, Insights, designed to provide a deeper understanding of the complexities and challenges within the pharmaceutical industry.   Joined by experts in their respective fields, we will give you the opportunity to discover the key scientific topics of current relevance to our sector   Here's what you can expect: 🔍 Crystal Clear: a deep dive into a scientific subject 🔬 Science Calling: a focus on a scientific innovation subject 📖 Tell Me a Story: from the viewpoints of partners, academics, peers, and patient organizations 🔮 Futures Forum: forward-looking content on the challenges encountered by the pharmaceutical industry 🗣️ Sounding Out Patients: when patients take the floor   In a few days, you will find our new article, where we delve into the world of SparingVision, a biotech startup dedicated to developing therapeutic solutions for retinal diseases. Discover this new section 👉 https://lnkd.in/ev6Gcehn Stay tuned for insights that will inspire and inform! 💡   #InsightsByServier #PharmaceuticalIndustry #Innovation #WeAreServier #MovedByYou

Assessing Healthcare Professionals’ Digital Skills in Cancer Care A systematic review was conducted to assess the digital skills of healthcare professionals in cancer care. The review identified four main skill categories: information technology, ethical practice, human-oriented relationship, and digital education and support. The findings highlight the importance of these skills for quality care and suggest the need for targeted education and research. For more details please click the link! https://lnkd.in/daCtGwQB #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical